Category: Clinical Breakthroughs
-
Testing Diabetes Drug Dosage
Northwestern Medicine physicians participated in a clinical trial to investigate the safety and efficacy of a drug for weight management in overweight or obese adults with type 2 diabetes.
-
Investigating Kidney Cancer Therapies
Two drugs known to improve survival for patients with metastatic renal cell carcinoma do not reduce the risk of cancer recurrence when administered after surgery, according to a recent clinical trial.
-
Reducing Antibiotic Overuse
Two simple behavioral interventions decreased the rate of unnecessary antibiotic prescriptions for acute respiratory tract infections, according to a recent paper co-authored by Northwestern Medicine investigator Stephen Persell, MD, MPH.
-
Investigating Physical Activity to Prevent Falls Among Older Adults
A recent clinical trial co-led by Mary McDermott, MD, ’92 GME, and colleagues found that increasing physical activity in sedentary older men and women did not prevent serious fall injuries.
-
Testing a New Therapy for Advanced Blood Cancer
A recent clinical trial conducted by Northwestern Medicine investigator Seema Singhal, MD, showed that the drug daratumumab is a safe and effective treatment for patients with advanced multiple myeloma.
-
Low Vitamin D Predicts Aggressive Prostate Cancer
A new Northwestern Medicine study showed that deficient vitamin D blood levels in men can predict aggressive prostate cancer.
-
Examining New Breast Cancer Therapy
A phase III clinical trial tested the effectiveness of a combination of two drugs and found they may be an effective and safe treatment for patients with metastatic breast cancer.
-
New Intravaginal Ring Enhances Drug Delivery
A team left by Northwestern Medicine biomedical engineer Patrick Kiser, PhD, designed an intravaginal ring equipped with a novel drug release mechanism that enables the delivery of a diverse array of drugs for extended durations.
-
Assessing Steroid Treatment for Women at Risk for Late Preterm Delivery
A new study suggests giving the steroid betamethasone to women at risk for late preterm delivery significantly reduces the rate of neonatal complications.
